Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer
{{output}}
Plasma cell-free tumor DNA, or circulating tumor DNA (ctDNA), from liquid biopsy is a potential source of tumor genetic material, in the absence of tissue biopsy, for EGFR testing. Our validation study reiterates the clinical utility of ctDNA next generation s... ...
